Zhong Guo Jing Ji Wang·2025-11-27 09:07Core Points - Kangwei Century (688426.SH) closed at 26.49 yuan, with a decline of 4.71%, currently in a state of breaking issue [1] - The company was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on October 25, 2022, with an initial offering price of 48.98 yuan per share [1] - The total number of shares publicly issued was 23,290,278, accounting for 25% of the total share capital after issuance [1] - The total funds raised amounted to 1,140.76 million yuan, with a net amount of 1,054.30 million yuan after deducting issuance costs, exceeding the original plan by 68.63 million yuan [1] - The funds are intended for projects including the industrialization of medical devices and biological testing reagents, marketing network construction, molecular detection product R&D, and working capital supplementation [1] Financial Details - The issuance costs totaled 86.45 million yuan, with CITIC Securities receiving underwriting fees of 64.49 million yuan [2] - CITIC Securities Investment Co., Ltd., a related subsidiary involved in the underwriting, was allocated 931,611 shares, representing 4.00% of the total shares issued [2] - On June 6, 2023, the company announced a dividend plan of 5.2 yuan (pre-tax) per 10 shares, with a bonus issue of 2 shares [2]